GRACEcast Cancer 101 Audio

GRACEcast Cancer 101 Audio

Por: cancerGRACE - H. Jack West, MD
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
300 episodios disponibles

Latest episodes of the podcast GRACEcast Cancer 101 Audio

Mostrando página 12 de 15

Dr. Larry Einhorn on "What Have Been the Most Significant Changes in Cancer Care over the Past Decade or Two?" 12/04/2013
Dr. Ravi Salgia on "Which patients do you send molecular marker testing for, and what tests do you seek?" 12/04/2013
Dr. Geoffrey Oxnard: Are Patients or Payers Objecting to Repeat Biopsy? 12/04/2013
Dr. Greg Riely on Muliplex Next Generation Sequencing and its Effect on Molecular Oncology Practice 11/04/2013
Dr. Phil Bonomi on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment 11/04/2013
Dr. Karen Kelly on "My Approach to Maintenance Therapy for Advanced NSCLC" 10/04/2013
Dr. David Spigel on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer 10/04/2013
Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (video) 09/04/2013
Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (audio) 09/04/2013
Dr. Sarah Goldberg: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy 08/04/2013
Drs. Ross Camidge and Corey Langer: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers? 08/04/2013
Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video) 07/04/2013
Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (audio) 07/04/2013
Dr. Lecia Sequist: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers? 05/04/2013
Dr. Heather Wakelee: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression? 05/04/2013
Dr. Ravi Salgia: How Do I Discuss the Side Effects of Targeted Therapies, as Compared with Chemotherapy? 03/04/2013
Dr. Karen Reckamp on "Which patients do you send molecular marker testing for, and what tests do you seek?" 03/04/2013
Dr. Greg Riely on "I just found out I have an EGFR mutation, and I'm in the middle of chemo. What now?" 31/03/2013
Dr. Geoffrey Oxnard on What Molecular Markers to Test for in Advanced NSCLC, and in Whom? 31/03/2013
Highlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy (video) 30/03/2013
« Primera ‹ Anterior 1 ... 10 11 12 13 14 15 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA